Trademark: ADVENT ADVANCES IN TYPE 2 IMMUNE DISEASES
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
ADVENT ADVANCES IN TYPE 2 IMMUNE DISEASES
Click here to search for trademarks similar to ADVENT ADVANCES IN TYPE 2 IMMUNE DISEASES
Proof of use for ADVENT ADVANCES IN TYPE 2 IMMUNE DISEASES
We do not have any records of a proof of use for ADVENT ADVANCES IN TYPE 2 IMMUNE DISEASES at this moment.
Click here to add a proof of use for ADVENT ADVANCES IN TYPE 2 IMMUNE DISEASES
Possible trademark infringements of ADVENT ADVANCES IN TYPE 2 IMMUNE DISEASES
Basic Information about ADVENT ADVANCES IN TYPE 2 IMMUNE DISEASES
- Serial Number
- 87636178
- Filing Date
- 06 Oct 2017
- Registration Number
- 5677678
- Registration Date
- 19 Feb 2019
- Mark Drawing Code
- 3
Classifications
Declare the trademark use of ADVENT ADVANCES IN TYPE 2 IMMUNE DISEASES on the blockchain with WikiTrademarks.io.
- First use of ADVENT ADVANCES IN TYPE 2 IMMUNE DISEASES anywhere
- No first use declared yet.
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 041
- US Codes
- 100; 101; 107
Who owns ADVENT ADVANCES IN TYPE 2 IMMUNE DISEASES?
1. Sanofi Biotechnology 75008 Paris
2. Sanofi Biotechnology 75008 Paris
3. Sanofi Biotechnology 75008 Paris
Correspondent
- Karen Lim
- Fross Zelnick Lehrman & Zissu, P.C.
- 151 WEST 42nd St.,17th Fl.
- NEW YORK, New York 10036
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io